• Waguih William IsHak, Katherine Collison, Itai Danovitch, Lili Shek, Payam Kharazi, Tae Kim, Karim Y Jaffer, Lancer Naghdechi, Enrique Lopez, and Teryl Nuckols.
• Cedars-Sinai Medical Center, Department of Psychiatry and Behavioral Neurosciences, Los Angeles, CA, USA.
• J Hosp Med. 2017 Feb 1; 12 (2): 118-125.

AbstractDepression among hospitalized patients is often unrecognized, undiagnosed, and therefore untreated. Little is known about the feasibility of screening for depression during hospitalization, or whether depression is associated with poorer outcomes, longer hospital stays, and higher readmission rates. We searched PubMed and PsycINFO for published, peer-reviewed articles in English (1990-2016) using search terms designed to capture studies that tested the performance of depression screening tools in inpatient settings and studies that examined associations between depression detected during hospitalization and clinical or utilization outcomes. Two investigators reviewed each full-text article and extracted data. The prevalence of depression ranged from 5% to 60%, with a median of 33%, among hospitalized patients. Several screening tools identified showed high sensitivity and specificity, even when self-administered by patients or when abbreviated versions were administered by individuals without formal training. With regard to outcomes, studies from several individual hospitals found depression to be associated with poorer functional outcomes, worse physical health, and returns to the hospital after discharge. These findings suggest that depression screening may be feasible in the inpatient setting, and that more research is warranted to determine whether screening for and treating depression during hospitalization can improve patient outcomes. Journal of Hospital Medicine 2017;12:118-125.© 2017 Society of Hospital Medicine.

11 keywords...

hide…